Falco Holdings Co Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Falco Holdings Co Ltd with three other
pharmaceutical manufacturers in Asia:
Dr. Lal PathLabs Ltd
sales of 12.03 billion Indian Rupees [US$168.48 million]
of which 100%
was Laboratories for pathological investigat),
Thyrocare Technologies Ltd
(4.03 billion Indian Rupees [US$56.41 million]
of which 91%
was Diagnostic Testing Services), and
Medical & Biological Laboratories Company Limited
(8.18 billion Japanese Yen [US$76.75 million]
of which 99%
was Reagent business).
Falco Holdings Co Ltd reported sales of ¥44.16 billion (US$414.18 million)
March of 2019.
decrease of 3.9%
versus 2018, when the company's sales were ¥45.96 billion.